To view this email as a web page, click here.
 
SPECIALTY DRUGS
 
Top 5 specialty drug management issues
Here are the top 5 specialty drug management issues faced by health plans and why these remain challenging.
Read more
 
Asthma biologic may reduce oral steroid use
A new trial for AstraZeneca's benralizumab shows promising results for severe asthma patients.
Read more
 
Popular insulin drug meets target in real-world study
Novo Nordisk recently announced the primary results from a study comparing Tresiba (insulin degludec injection 100 units/mL, Novo Nordisk) to insulin glargine 100 units/mL.
Read more
 
SURVEY
 
State of the Industry Survey 2017
Take three minutes to answer our State of the Industry Survey. As a thank-you to survey-takers, when the survey closes, we will hold a drawing to give away not one, but two $200 Visa gift cards.
Take survey
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.